Article Individual Patient-Centered Specialization 
GeriPal
AUGUST 4, 2022
A year ago we did our first “Deprescribing Super Special”. Next up, we chat with Liz Bayliss about her JAMA IM article that studied whether increasing awareness about deprescribing prior to primary care visits can reduce the use of potentially inappropriate long-term medications for individuals with cognitive impairment.
Aspiring Minority Doctor
DECEMBER 17, 2023
Okay, now I'll admit I've done a horrible job of keeping up with the blog lately especially given that this is only my fifth post of the year, but today is still super special for me. This blog has connected me with so many incredible individuals over the years, and it let me know the importance of sharing our stories.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeriPal
JULY 19, 2024
Joseph Gaugler is the Director of the Center for Healthy Aging and Innovation at the University of Minnesota, director of the BOLD Public Health Center of Excellence on Dementia Caregiving, and Editor-in-Chief of the Gerontologist. What should we use to screen individuals? There’s an article about her in New York Times.
GeriPal
NOVEMBER 9, 2023
On the other hand, there is a concerning side, described in this Guardian article titled, I’m a life coach, you’re a life coach: rise of an unregulated industry. If they’re a beginning fellow, that’s a very different coaching situation than coaching the chief medical officer or the president of a medical center.
The Clinical Problem Solvers
FEBRUARY 8, 2023
There is a special emphasis on the use of public health models that prioritize harm reduction and person-centered care to prevent drug-related fatalities and curb the opioid epidemic along lines of race and class. This discussion is hosted by Ashley Cooper, Sudarshan Krishnamurthy, and new team member Gillette Pierce.
GeriPal
JANUARY 25, 2024
He also found gaps, including very few studies of patients with lung disease, and little impact of trials on quality of life. The article we discuss today, also published in JAMA , addresses these two gaps. Your research is a lot in this patient population, right? Big randomized control study that came out. Lyndsay: Yes.
GeriPal
OCTOBER 17, 2024
We talk about what is heart failure, particularly HFpEF, how we treat it (including the use of sodium–glucose cotransporter-2 inhibitors (SGLT2’s), and how we should apply guidelines to individual patients, especially those with multimorbidity who are taking a lot of other medications. When I see a patient? This is Eric Widera.
Expert insights. Personalized for you.
104 
Let's personalize your content